Innovative Combination Immunotherapy for Metastatic Triple Negative Breast Cancer (TNBC): A Multicenter, Multi-Arm Translational Breast Cancer Research Consortium Study

Status: Open to Accrual

Learn more:

• https://clinicaltrials.gov/study/NCT03971409

Study Contact: studies@hoosiercancer.org; (317) 921-2050.